AbL Diagnostics SA
PAR:ABLD

Watchlist Manager
AbL Diagnostics SA Logo
AbL Diagnostics SA
PAR:ABLD
Watchlist
Price: 3.1 EUR Market Closed
Market Cap: 49.9m EUR

Intrinsic Value

The intrinsic value of one ABLD stock under the Base Case scenario is 0.58 EUR. Compared to the current market price of 3.1 EUR, AbL Diagnostics SA is Overvalued by 81%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABLD Intrinsic Value
0.58 EUR
Overvaluation 81%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
AbL Diagnostics SA

What is Valuation History?
Ask AI Assistant
What other research platforms think about ABLD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ABLD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for AbL Diagnostics SA.

Explain Valuation
Compare ABLD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ABLD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AbL Diagnostics SA

Current Assets 7.7m
Cash & Short-Term Investments 912.2k
Receivables 5.9m
Other Current Assets 883.4k
Non-Current Assets 3.4m
PP&E 429.4k
Intangibles 2.8m
Other Non-Current Assets 200.2k
Current Liabilities 2.4m
Accounts Payable 1.1m
Accrued Liabilities 223.9k
Other Current Liabilities 1m
Non-Current Liabilities 1.8m
Long-Term Debt 1.8m
Efficiency

Free Cash Flow Analysis
AbL Diagnostics SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
AbL Diagnostics SA

Revenue
5.4m EUR
Operating Expenses
-5.7m EUR
Operating Income
-213.8k EUR
Other Expenses
677.2k EUR
Net Income
463.4k EUR
Fundamental Scores

ABLD Profitability Score
Profitability Due Diligence

AbL Diagnostics SA's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Sustainable 3Y Average Gross Margin
Low Net Margin
Low 3Y Average Net Margin
44/100
Profitability
Score

AbL Diagnostics SA's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

ABLD Solvency Score
Solvency Due Diligence

AbL Diagnostics SA's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
74/100
Solvency
Score

AbL Diagnostics SA's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABLD Price Targets Summary
AbL Diagnostics SA

Wall Street analysts forecast ABLD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABLD is 6.28 EUR with a low forecast of 6.22 EUR and a high forecast of 6.47 EUR.

Lowest
Price Target
6.22 EUR
101% Upside
Average
Price Target
6.28 EUR
103% Upside
Highest
Price Target
6.47 EUR
109% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ABLD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ABLD stock?

The intrinsic value of one ABLD stock under the Base Case scenario is 0.58 EUR.

Is ABLD stock undervalued or overvalued?

Compared to the current market price of 3.1 EUR, AbL Diagnostics SA is Overvalued by 81%.

Back to Top